29/11/2015 23:08:01 Cookie Policy Free Membership Login

Tristel Share Chat - TSTL

Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.71% 140.50 139.00 142.00 141.50 140.50 141.50 42,480 13:23:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 15.3 2.6 5.4 25.8 59.08

Tristel Share Discussion Threads

Showing 2201 to 2225 of 2225 messages
Post New Message
Chat Pages: 89  88  87  86  85  84  83  82  81  80  79  78  >>
FWIW, A French study from 2007 .... Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit - S.Nseir1, C.Blazejewski1, R.Lubret1, F.Wallet, R.Courcol and A.Durocher1, hTTp://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)62955-4/pdf "We conclude that admission to an ICU room previously occupied by a patient with MDR P.aeruginosa or A.baumannii is an independent risk factor for acquisition of these bacteria by subsequent room occupants. This relationship was not identified for ESBL-producing GNB."piedro
Welcome aboard. Hopefully plenty more to come!Tristel has quite a few interesting irons in the fire and its core business is strong and strengthening given the need for better and cheaper disinfection approaches that Tristel has. Regards,Source.source
This share is on fire. Only held just over a week an up over 20% withe the divi - wish I bough earlier but at least I am in itdavr0s
so that's what it looks like!!mfhmfh
Thanks for the informative conversation folks, apadapad
Safe disinfection process - Enables the decontamination of endoscopes and ultrasound equipment - Quick turnaround of instruments, speeding up patient throughput - Significant cost saving in comparison to fully automated washers http://www.stella-performance.com/piedro
Not promoting but they are all aware of it as Hospital Consultants are under pressure (as is everyone in the NHS) to cut costs.mfhmfh
mfhmfh, Thank you for the explanation. At your ENT seminar were they promoting the Tristel Wipes System?piedro
I've been invested here for a while as my job is in the healthcare service. If you read the RNS from 11.11.14 titled 'NZ ENT study shows Tristel Wipes System benefits' it suggests that Tristel products are far superior to others in eliminating infection and also far cheaper which is what the NHS needs right now. Naso-endoscopes are what ENT(Ear, nose throat) surgeons put through people's noses and down their throat to check for things. So if Tristel products are better than the rest and cheaper than current measures, hopefully they'll be utilised more in the UK in the NHS and private setting. Hopefully sales should be better abroad in both government and private hospitals if money can be saved. The USA is obviously the big market and I would say the Gulf Arab world as well due to the local population as well as the significant number of ex-pats. All IMHOmfhmfh
mfhmfh, I don't have much idea about Naso-endoscope cleaning - can you explain a bit TIA.piedro
FWIW, QUALITY BUILDINGS, QUALITY CARE NOVEMBER 2015 hTTp://www.bpf.org.uk/sites/default/files/resources/BPF-Quality-Buildings-Quality-Care-Nov-15-web_0.pdfpiedro
I went to an ENT seminar on the weekend. Just from the Naso-endoscope cleaning point of view this company's shares are definitely worth holding on to. Not that much idea about all it's other products. IMHO.mfhmfh
Looks like this may squeeze up to 150p to 160p as rightly no one is selling given Tristels positive progress going fwd. (Can't be early good news on USA already could it?)Regards Source.source
metis20, Thank you for the link - added to headerpiedro
Good to know that ClO2 already has approval in USA for “many applications” :- Http://www.clordisys.com/whatcd.php "Chlorine dioxide has been recognized as a disinfectant since the early 1900s and has been approved by the US Environmental Protection Agency (EPA) and the US Food and Drug Administration (FDA) for many applications. It has been demonstrated effective as a broad spectrum, anti-inflammatory, bactericidal, fungicidal, and virucidal agent……" For a selection of regulatory approval initiatives, see page 11 of Http://www.tristel.com/wp-content/uploads/2015/02/12.10.15-TSTL-Preliminary-results-presentation.pdf Another useful “starter” link (see Piedro's links in his introduction above:- Http://www.lenntech.com/processes/disinfection/chemical/disinfectants-chlorine-dioxide.htm "Can microorganisms become resistant against chlorine dioxide? Chlorine dioxide as a disinfectant has the advantage that it directly reacts with the cell wall of microorganisms. This reaction is not dependent on reaction time or concentration. In contrast to non-oxidizing disinfectants, chlorine dioxide kills microorganisms even when they are inactive. Therefore the chlorine dioxide concentration needed to effectively kill microorganisms is lower than non-oxidizing disinfectant concentrations. Microorganisms cannot built up any resistance against chlorine dioxide."metis20
Ok fair points metis. Something is driving the current rise. It certainly is powering ahead. I remember the 40p days which is good :) Growth is showing no sign of slowing anyway so hopefully we can hit 150p. I think this stock is fairly illiquid and so it moves substantially on not a lot of buys.mach100
Experts Partner to Address Resistant Bacteria Through Antibiotic Stewardship, Environmental Hygiene Stuart Levy, MD, president of the Alliance for the Prudent Use of Antibiotics (APUA), and Rosie Lyles, MD, MHA, MSc, head of clinical affairs for Clorox Healthcare, share their perspectives on antimicrobial stewardship in the hospital and in the community. http://tinyurl.com/nunk4vm - Mr. Levy seems to be hung up on the Triclosan debatepiedro
Looks as if a new strain of a bacterium can spread worldwide in less than 10 years. This from a paper published in December 2013:- “In 2008, a previously unrecognized Escherichia coli clonal group, sequence type 131 (ST131), was identified in nine countries, spanning three continents. Today, ST131 is the dominant extraintestinal pathogenic E. coli (ExPEC) strain worldwide, but retrospective analyses suggest that the pandemic emergence of ST131 took place over a period of fewer than 10 years .” For the link to the paper - Http://mbio.asm.org/content/4/6/e00377-13 - it is possible to download the whole paper as a pdf free from the screen obtained from this link. And for the current antibiotic resistance scare see, for example Http://www.bbc.co.uk/news/health-34857015metis20
Mach100 - I was not thinking of ClO2 being used in China. I was thinking however that apparently it takes but two or three years for a new strain of bacterium to spread world-wide. In other words into areas where Cl02 is already in use. The current scare is about a bacterium which has developed resistance to all known antibiotics - and is currently located in China and India. There is also evidence that it has spread to Laos and Malaysia Others, more in the know than I, care to comment?metis20
Plenty more to go for Tristel I think - even without factoring in USA developments this has a lot of growth ahead of it. Firm hold for me and wish I'd bought more earlier. Regards,Source.source
Interesting thesis metis20 but my understanding is that Tristel has 'given up' on China .TSTL tried before to enter the market but working practises in China are not conducive to doing business. Therefore at least in the case of China the uplift will be minimal.mach100
IMO this post ex-div share price strength may well be linked to the current China/India antibiotic resistance scare - if there are no drugs which can zap the bacteria once they are inside the victim, then there will be even more attention paid, in the hospital and GP surgery environments, to eradicating the bacteria before they can enter the patient .metis20
Still going very strong and has breached my 130p target price. Wonder where this one will stop? It will surely have doubled from this price once FDA approval is bagged. A stellar performer!mach100
... but it would seem that Anistel is not interested.piedro
The competition is at the events ...piedro
Chat Pages: 89  88  87  86  85  84  83  82  81  80  79  78  >>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 151129 23:08